Correlation Between Blockmate Ventures and Pfizer

Can any of the company-specific risk be diversified away by investing in both Blockmate Ventures and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blockmate Ventures and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Blockmate Ventures and Pfizer Inc CDR, you can compare the effects of market volatilities on Blockmate Ventures and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blockmate Ventures with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blockmate Ventures and Pfizer.

Diversification Opportunities for Blockmate Ventures and Pfizer

0.53

Correlation Coefficient

Blockmate Ventures  Pfizer

Very weak diversification

The 3 months correlation between Blockmate and Pfizer is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Blockmate Ventures and Pfizer Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc CDR and Blockmate Ventures is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blockmate Ventures are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc CDR has no effect on the direction of Blockmate Ventures i.e., Blockmate Ventures and Pfizer go up and down completely randomly.

Pair Corralation between Blockmate Ventures and Pfizer

Assuming the 90 days trading horizon Blockmate Ventures is expected to generate 12.92 times more return on investment than Pfizer. However, Blockmate Ventures is 12.92 times more volatile than Pfizer Inc CDR. It trades about 0.07 of its potential returns per unit of risk. Pfizer Inc CDR is currently generating about 0.06 per unit of risk. If you would invest  13.00  in Blockmate Ventures on December 3, 2024 and sell it today you would earn a total of  1.00  from holding Blockmate Ventures or generate 7.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Blockmate Ventures  vs.  Pfizer Inc CDR

Blockmate Ventures

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Blockmate Ventures are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Blockmate Ventures showed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer Inc CDR

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc CDR are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Pfizer is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Blockmate Ventures and Pfizer

The main advantage of trading using opposite Blockmate Ventures and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blockmate Ventures position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.

The idea behind Blockmate Ventures and Pfizer Inc CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.